Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...

DUBLIN--(BUSINESS WIRE)--Mainstay Medical Holdings plc today announced the publication of data from a single center, real-world study with one-year clinical follow-up of patients selected from the ...

When Dennis Bassett was in his 20s, he saw a stalled car and offered to push it for the owner. As he was assisting, he twisted his back and heard a “squishing sound.” “I was helping, being a good ...

Low back pain is one of the most frequently reported complaints in the military. We all joke about it, especially as we get older. We groan when we stand up. We exaggerate the effort it takes to put ...

A growing body of research points to this overlooked structure as the missing piece in back pain treatment Back pain remains one of the most common health complaints worldwide, affecting an estimated ...

Fresh off earning an updated FDA clearance for its flagship neuromodulation device, Mainstay Medical has closed an equity financing round to help expand the device’s global presence. The Irish company ...

Mainstay Medical is a medical device company focused on commercializing its innovative implantable Restorative Neurostimulation TM system, ReActiv8 ®, for people with disabling mechanical CLBP.